Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Clear all

286 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20019
20026
200314
20045
20057
20064
200715
200814
200915
201013
20115
20128
201312
201411
20158
201611
20178
201811
20196
20209
202113
202213
20235
20248
202517
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Terminated55
Recruiting30
Active, not recruiting14
Unknown status13
Not yet recruiting7
Withdrawn5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company18
Hoffmann-La Roche14
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.13
Otsuka Pharmaceutical Development & Commercialization, Inc.12
Pfizer11
National Institute on Aging (NIA)8
Avid Radiopharmaceuticals6
Bristol-Myers Squibb6
GE Healthcare6
H. Lundbeck A/S6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease286
Dementia82
Cognitive Dysfunction40
Psychomotor Agitation24
Memory Disorders16
Brain Diseases15
Neurodegenerative Diseases15
Mental Disorders14
Nervous System Diseases12
Central Nervous System Diseases9

Trials

Showing 26 to 50 of 286. Each trial links to its page on Pharma Observatory.

186 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.